ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
BNP Paribas Issuance

BNP Paribas Issuance (P14Y18)

0.00
0.00
(0.00%)
Closed October 10 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
0.00
Financial Volume
-
VWAP
-
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560099.75104.8578.11496.41625395DE
2600099.6104.8578.11396.41625395DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
1VARVarta AG
3.306 €
(74.92%)
199.3k
WSIAVSiav Spa
0.0489 €
(74.64%)
48.5k
1ADJAdler Group SA
0.322 €
(72.75%)
45.8k
WAAT26AA Tech SpA
0.0324 €
(29.60%)
25k
1IAGInternational Consolidated Airlines Group SA
2.336 €
(13.40%)
169.5k
WDIT24Destination Italia Spa
0.0012 €
(-25.00%)
25.91k
WTWL24TraWell Co SA
0.2164 €
(-22.66%)
9.12k
WHQF25High Quality Food Spa
0.02 €
(-20.32%)
2k
WABTGAlfio Bardolla Training Group Spa
0.196 €
(-19.77%)
1.54k
FDAFidia
0.126 €
(-14.29%)
4.2M
TITTelecom Italia SpA
0.2551 €
(1.23%)
172.39M
ISPIntesa Sanpaolo Spa
3.8075 €
(0.57%)
49.97M
TITRTelecom Italia
0.2985 €
(1.60%)
40.63M
SPMSaipem Spa
2.011 €
(0.25%)
16.88M
ENELEnel Spa
7.007 €
(0.43%)
12.87M

Discussion

View Full Feed
Swampy83 Swampy83 4 minutes ago
Completely agree with you. What is he waiting for? Why hold it down?
IDVV
ignatiusrielly35 ignatiusrielly35 5 minutes ago
Keep repeating your “kick the can” slogan, son. Or you could do your job and come up with something original that requires actual thought.
AVXL
Nezitic Nezitic 5 minutes ago
Address Updated:
🔴 208 East 51 Street, Suite 112, New York, NY, 10022, United States
🟢 1159 2nd Avenue, Ste 454, New York, NY, 10065, United States
GAHC
lambchops lambchops 6 minutes ago
Hey this is a "Mom and Dad send money!" message I used to send my parents when I was in college. and I had no money at the end of the month.
BTW they never did...But it was worth a try.

LC

WDRP
WDRP
wshaw14 wshaw14 6 minutes ago
https://finance.yahoo.com/news/49-ownership-skeena-resources-limited-112245162.html
SKE
lakers17 lakers17 7 minutes ago
You want me to list the very long list of NSAV red flags? 🤣🤣🤣 NSAV has scam written all over it, led by the three in management,
NSAV
lighter than AIR lighter than AIR 7 minutes ago
Good call Dan…as that’s exactly what happened…there was actually a negative surge in the Bay…the water got sucked out by the circular wind from the north.
CBRF
wshaw14 wshaw14 8 minutes ago
https://www.fool.com/investing/2024/10/08/why-energy-transfer-is-my-top-investment-for-passi/
ET
ImjinBridger ImjinBridger 9 minutes ago
My suspicion level is slowly rising that the silk may not be of sufficient quality
I had that same thought recently. It's possible that the silk that coming out of Bam-1 worms may be only slightly better than traditional silk. All we know is that they seem to be scaling up the production of s
KBLB
JohnnyRotton JohnnyRotton 9 minutes ago
Jarred had been working the projects for years, so when he took over he could hit the ground running.

Your spill is a lie, just an outright lie.
NBRI
oceans11 oceans11 10 minutes ago
“Has to be the most bizarre stream of consciousness or unconsciousness I’ve ever seen.”
I’d say that describes your ramblings perfectly.
Kudos on your level of self-awareness.
So rare on these boards…
HIRU
IanFromSI IanFromSI 11 minutes ago
In 2024, Revance Therapeutics (RVNC) faced substantial costs and operating expenses to support the revenues from Daxxify and the RHA Collection. For the year, RVNC projected total GAAP operating expenses between $430 million and $460 million. These expenses encompass research and development (R&D),
RVNC
lambchops lambchops 11 minutes ago
SIPC up 10%. Bull's running!

LC

SIPC
SIPC
lambchops lambchops 11 minutes ago
SIPC up 10%. Bull's running!

LC

SIPC
SIPC
dstock07734 dstock07734 12 minutes ago
Gary,

What kind of approval will come from UK? DCVAX-L + Poly-ICLC

Should DCVAX-L deserve Platform Technology Designation from FDA?

Why would a small company like Oncovir keep secret for partnerships?

Don't treat this DCVAX-L as a singular
NWBO
wshaw14 wshaw14 12 minutes ago
TORONTO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) today reported its second quarter (Q2) and half year (H1) results for the period ended June 30th, 2024.
https://www.globenewswire.com/en/news-release/2024/08/07/2926501/37420/en/McEwen-Mining-Q2-2024-Results.
MUX
JohnnyRotton JohnnyRotton 12 minutes ago
This should be stickied

Gitreal has personally cost me major bucks because he drove folks out of stocks that went up eventually,

But also by driving stocks out of business, keeping them from raising sufficient funding.

He has cost folks millions over the
NBRI
ace65 ace65 12 minutes ago
Dont like GTSM parking at .0009 ask with 10k showing though.
But yes all buys today and best volume in a month.
HMLA
lambchops lambchops 14 minutes ago
Hey Ben! Don't be a rat. Be cool, and don'r ya' think it's time to get this NFT thing goin'!
Thank you for you due consideration.

L'il 'ol Lambchops.

NFTM
NFTM
OINGO BOINGO OINGO BOINGO 14 minutes ago
Having a laugh. A pretty good one at that
XALL
oceans11 oceans11 14 minutes ago
So are trips.
Oh wait-
TGGI
varmit varmit 15 minutes ago
Waiting for this piece of filth stock to do something !!!!!

I’ve owned gncp for 14 years and nothing ever happens

It’s like a fake company to pay management salaries and dilute shares to pay them !!!!

A kid lemonade stand makes more in a day than gncp h
GNCP
Bopper155 Bopper155 16 minutes ago
LOL. Team CCL for a win. Yes, trippininLaCoste, you started with a nice lead off double, then a walk, a single by TESLIN, then the big home run call by chris3403 !!! CCL wins !!!

CCL longs win !!!
CCL
ace65 ace65 17 minutes ago
All sells today,hopefully flippers are out.Like to see buying to close out the week on a high note.
KITL
IanFromSI IanFromSI 18 minutes ago
Revance Therapeutics (RVNC) generated significant revenue from both Daxxify and its partnership with Teoxane’s RHA product line in 2024. In Q2 2024, revenue from Daxxify, primarily in the aesthetics segment, grew by 27% year-over-year, reaching $28.7 million. Additionally, the RHA Collection, which
RVNC